A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation (Q36481665)

14 August 2017

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation (English)

1 reference

cost-effectiveness analysis

14 August 2017

1 reference

4

1 reference

14 August 2017

Sean P David

3

0 references

Nicky J. Welton

object named as

Nicky J Welton

series ordinal

1

0 references

Elaine C Johnstone

series ordinal

2

object named as

Elaine C Johnstone

1 reference

14 August 2017

1 January 2008

1 reference

Nicotine and Tobacco Research

14 August 2017

1 reference

14 August 2017

10

1 reference

14 August 2017

231-240

1 reference

14 August 2017

1

1 reference

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Nicotine replacement therapy for long-term smoking cessation: a meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Pharmacogenetics and nicotine addiction treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Smoking cessation treatment: pharmacogenetic assessment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Antidepressants for smoking cessation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Nicotine replacement therapy for smoking cessation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Establishment of genetic associations for complex diseases is independent of early study findings

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

The impact of learning of a genetic predisposition to nicotine dependence: an analogue study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Applying genetic approaches to the treatment of nicotine dependence

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Pharmacogenetics and psychopharmacotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Pharmacogenomics: translating functional genomics into rational therapeutics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Bayesian synthesis of epidemiological evidence with different combinations of exposure groups: application to a gene-gene-environment interaction.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Pharmacogenetic investigation of smoking cessation treatment

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257987

Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18188764

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The effectiveness of the nicotine patch for smoking cessation. A meta-analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18188764

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18188764

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/14622200701767761

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

2257987